ArticleBMC musculoskeletal disorders2026
A multivariable model for perioperative transfusion risk in elective primary THA.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPerioperative blood transfusion remains a relevant concern in elective total hip arthroplasty (THA), as it is associated with adverse outcomes and increased healthcare utilization. Reliable, procedure-specific risk stratification tools based on routinely available clinical data are needed to support individualized perioperative blood management.
methodsThis retrospective cohort study included consecutive patients undergoing elective primary THA between 2016 and 2023 at a single certified arthroplasty center. Demographic data, comorbidity burden (ASA classification), perioperative laboratory values, operative characteristics, blood loss parameters, and transfusion data were extracted from a prospectively maintained registry. The primary outcome was perioperative allogeneic red blood cell transfusion. Univariable and multivariable logistic regression analyses were performed to identify independent predictors of transfusion. Model performance was assessed using receiver operating characteristic analysis and calibration testing.
resultsA total of 648 patients were included, of whom 104 (16.0%) required perioperative transfusion. Transfused patients demonstrated lower preoperative hemoglobin levels, greater perioperative hemoglobin decline, and higher total and hidden blood loss. On multivariable analysis, lower preoperative hemoglobin, longer operative time, greater intraoperative blood loss, and lower body mass index were independently associated with transfusion, while male sex was inversely associated. Higher comorbidity burden (ASA ≥ III) showed a borderline association after adjustment. The final model demonstrated excellent discrimination with an area under the curve of 0.878 and good calibration.
conclusionExternal validation of the present model is required before routine clinical application. Perioperative transfusion following elective primary THA can be predicted with good discriminative performance using routinely available clinical variables, supporting perioperative risk assessment and individualized blood management, although its applicability for preoperative patient counseling is limited. LEVEL OF EVIDENCE: Level III (retrospective cohort study).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.